| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |